About this trial

The goal of this study is to uncover sleep and circadian mechanisms contributing to adverse metabolic health. The protocol is a 21 day (7 outpatient days, 14 inpatient days) mechanistic randomized-crossover study designed to identify the impact of chronic sleep restriction and circadian timing, independently and in combination on energy metabolism and identify the independent and combined effects on glucose tolerance.

Eligibility criteria

Qualifiers

Between 18 and 40 years of age

Drug free

Established disease-free status

Disqualifiers

Dietary restrictions

Participants who choose not to or cannot consume dairy products (milk, yogurt, cheese, ice cream)

Body Composition

Psychiatric/psychological suitability

Trial design

Treatments tested in this trial

  • Sleep Restriction

Treatment groups

20 Participants
are divided into 2 treatment groups

Locations

1
Oregon Health & Science University97239, PortlandOregon, United States

Sponsors and collaborators

Oregon Health and Science University

Lead sponsor